In Plain English: The Keynote 716 Clinical Trial
…(metastatic) melanoma, no drug has been tested in the standard clinical trial format for Stage II melanoma. Qualified patients for…
In Plain English: The Keynote 716 Clinical Trial
…(metastatic) melanoma, no drug has been tested in the standard clinical trial format for Stage II melanoma. Qualified patients for…
,
Survivor Spotlight: Brian Halvorson
Melanoma and The Sun By Mara Klecker More than 11,000 students have heard Brian Halvorson tell the story of…
,
Survivor Spotlight: Melissa Papock, Founder of Cabana Life
…soon revealed that the spot was an amelanotic melanoma, a form of melanoma in which the malignant cells have little…
,
,
A Heartfelt Thank You To Our Auction Sponsors
…with melanoma on October 13th, 2018. Gina has been raising funds for AIM at Melanoma in her honor by hosting…
,
President’s Letter | November 2022
…the AIM community. Thank you for your support of AIM at Melanoma. Happy Thanksgiving to you and your family. Samantha…
,
The State of Sunscreen: 2024 Updates
…their risk factors is crucial. The most prevalent forms are basal cell carcinoma, squamous cell carcinoma, and melanoma, with melanoma…
Side Effect Central: Lichen Planus Explained
Side Effect Central is a new series of articles designed to help patients with melanoma and their caregivers understand the…
,
Your Style Can Save Lives – Lilly Pulitzer Giving Day is Here!
…us for Lilly Pulitzer’s Community Giving Day, you’re not just shopping—you’re turning fashion into impact. Together, we can create a…
,
2026 National Sunscreen Partner
…melanoma community. Sun protection is one of the most effective tools we have in reducing melanoma risk. And it’s the…
,
The FDA Just Approved a New Sunscreen Ingredient—What It Means for Patients with Skin Cancer, Survivors, and the General Public
…of ultraviolet radiation responsible for skin damage and increased melanoma risk. UVB rays are the primary cause of sunburn and the main…
,
Recent Posts
Aug. 31, 2026
Women in Melanoma: A New Chapter in Europe
Aug. 31, 2026
The Legal & Financial Side of a Diagnosis: What No One Tells You
Aug. 19, 2026
Positive Phase 3 Results for Personalized mRNA Therapy in Melanoma
Aug. 07, 2026
RP1 Approved: A Long Road to a New Option for Patients
Aug. 06, 2026